|Bid||1.0400 x 800|
|Ask||1.0500 x 1200|
|Day's Range||1.0340 - 1.1000|
|52 Week Range||1.0100 - 13.3400|
|Beta (5Y Monthly)||1.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2023 - Nov 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.67|
Subscribe to Yahoo Finance Plus to view Fair Value for NGM
Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science, agtech and advanced technology mega campuses in AAA innovation cluster locations, has been strategically developing and operating high-quality Labspace® infrastructure for, and investing in, some of the most advanced and innovative biopharmaceutical companies leveraging artificial intelligence (AI) and machine learning (ML) platform
Repare Therapeutics Inc. (RPTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Insiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s ( NASDAQ:NGM ) stock at an average price of...